"We've discovered a way to greatly improve the accuracy of gene-editing technology by replacing the natural guide molecule it uses with a synthetic one called a bridged nucleic acid, or BNA," said the study lead.
Using single-molecule FRET experiments authors show that BNANC incorporation slows Cas9 kinetics and improves specificity by inducing a highly dynamic crRNA–DNA duplex for off-target sequences, which shortens dwell time in the cleavage-competent, “zipped” conformation.
The team has filed a patent on their discovery and is hoping to partner with the pharmaceutical industry to incorporate it into a therapeutic.
Interest in gene-editing technology has been rapidly rising since the discovery of CRISPR/Cas9. This system is naturally present in bacteria, which use it for protection against their natural predators, called bacteriophages.
"It allows bacteria to store information about previous infections and then use it to seek out and destroy the DNA of new invaders by cutting it," explained the lead.
"What researchers have realized is that this system can be programmed to cut a specific DNA sequence in a human cell also, allowing us to edit our genes. One of the main issues, however, is that the system is not perfectly specific--sometimes it cuts a similar but incorrect gene."
Using its natural RNA guide molecule, the Cas9 system is quite accurate, only making a mistake about one per cent of the time, author noted.
"However, given that there are trillions of cells in the human body, even one percentage off is quite significant, especially because gene editing is permanent. One wrong cut and a patient could end up with a serious condition like cancer."
The new BNA guide molecule that the team developed was shown to be much more stable and stringent in its quest for finding the right DNA to cut.
"Our research shows that the use of bridged nucleic acids to guide Cas9 can improve its specificity by over 10,000 times in certain instances--a dramatic improvement," said the lead.
Though gene-editing technology still has several hurdles to overcome, including the challenge of how to deliver it effectively into the human body, it may someday be used to treat a wide variety of genetic diseases, from muscular dystrophy to hemophilia and various cancers.
https://www.folio.ca/breakthrough-brings-gene-editing-medicine-one-step-closer-to-patient-applications/
https://www.nature.com/articles/s41467-018-03927-0
Latest News
Microfluidic systems resemb…
By newseditor
Posted 11 May
Neurotransmitter classifica…
By newseditor
Posted 11 May
Uncovering the secret of lo…
By newseditor
Posted 10 May
A cubic-millimeter fragment…
By newseditor
Posted 10 May
mtDNA transcription Inhibit…
By newseditor
Posted 09 May
Other Top Stories
Molecular landscapes of human hippocampal immature neurons across l…
Read more
DNA recombinations are implicated in both development and disease
Read more
Molecular signatures of age-related macular degeneration
Read more
Key mechanism controlling skin regeneration
Read more
Hyaluronic acid awakens stem cells to repair damaged muscle
Read more
Protocols
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Parasympathetic neurons der…
By newseditor
Posted 07 May
Non-invasive measurements o…
By newseditor
Posted 05 May
A validation strategy to as…
By newseditor
Posted 04 May
Publications
Vascular network-inspired f…
By newseditor
Posted 11 May
Neurotransmitter classifica…
By newseditor
Posted 11 May
Forward programming human p…
By newseditor
Posted 10 May
Cyclophilin A supports tran…
By newseditor
Posted 10 May
Sortases: structure, mechan…
By newseditor
Posted 10 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar